Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
about
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progressionCell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristicsEmphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancerTACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancerThymidine kinase assay in canine lymphoma.Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancerAutomatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections.Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections.Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a reviewExosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.Elevated prostate specific antigen and reduced 10-year survival among a cohort of Danish men consecutively referred from primary care to an urological department during 2005-2006.Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Future prospects in the diagnosis and management of localized prostate cancer.
P2860
Q21203667-E6C3AA13-163F-4906-94D9-2D05ED78D90DQ28482384-E14D05EA-A8C2-4BD0-A574-E0024F5453E6Q28709995-3214A6D3-F050-4DBD-AF00-BFF14447831AQ33636574-49E92ECD-5B86-4325-9F3C-A530EE15C04FQ34246274-00098B22-A5A6-4F9C-91CC-4496BA24DC92Q34455096-B00C744E-404B-49C3-94CB-873D22E80E70Q34980054-4BD325B2-A1D8-487C-853C-7694575520D2Q36118895-5B39D86F-A32C-402A-A1C0-42B880AF4BD5Q36852430-B6C2860D-D921-45F8-8423-4AC5A069C233Q38253055-E4E24FAC-EB99-4B16-B81F-A2B5AEDC509DQ38774692-80182E71-C2E7-4538-8862-09A5755A233FQ39457666-8FED77AE-0421-485D-8D9E-6B19644E8118Q40529859-EA847783-E55F-4D47-8AA5-59C7854946BFQ41695208-214D1FE8-19C2-4362-9026-1A9A390774D9Q42022308-7985100F-3FDE-4F14-B59B-D615110B2BB3Q42184292-1EF5C20F-3D75-4097-93C6-76D71D305805Q51348320-5738D54B-A417-4ECB-9CD3-AC9CC147ED68
P2860
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@en
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@nl
type
label
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@en
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@nl
prefLabel
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@en
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@nl
P2860
P1433
P1476
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
@en
P2093
Anders Bjartell
Daniel M Berney
P2860
P356
10.3109/0284186X.2010.531284
P478
50 Suppl 1
P577
2011-06-01T00:00:00Z